Yang Y - Search Results

1

Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy.

An SJ, Huang YS, Chen ZH, Su J, Yang Y, Chen JG, Yan HH, Lin QX, Yang JJ, Yang XN, Zhou Q, Zhang XC, Wu YL. An SJ, et al. Among authors: yang xn, yang jj, yang y. Med Oncol. 2012 Jun;29(2):627-32. doi: 10.1007/s12032-011-9924-x. Epub 2011 Apr 3. Med Oncol. 2012. PMID: 21461966

2

[The Impact of Smoking Status on the Efficacy of Erlotinib in Patients with Advanced Non-small Cell Lung Cancer.].

Huang Y, Yang J, Yang Y, Huang Y, Liao R, Wu Y. Huang Y, et al. Among authors: yang y, yang j. Zhongguo Fei Ai Za Zhi. 2009 Dec 20;12(12):1266-70. doi: 10.3779/j.issn.1009-3419.2009.12.08. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723381 Free article. Chinese.

3

[Efficacies of gefitinib versus paclitaxel/carboplatin for patients with advanced pulmonary adenocarcinoma].

Lou N, Yang J, Yan H, Zhou Q, Liao R, Xu C, Huang Y, Yang X, Yang Y, Gan B, Wu Y. Lou N, et al. Among authors: yang x, yang y, yang j. Zhonghua Yi Xue Za Zhi. 2014 Aug 13;94(30):2337-41. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25399973 Clinical Trial. Chinese.

4

Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy.

Wang YY, Bai ZL, He JL, Yang Y, Zhao R, Hai P, Zhe H. Wang YY, et al. Among authors: yang y. Dis Markers. 2016;2016:3740794. doi: 10.1155/2016/3740794. Epub 2016 Mar 20. Dis Markers. 2016. PMID: 27087737 Free PMC article.

5

CT Appearance Pattern After Stereotactic Body Radiation Therapy Predicts Outcomes in Early-Stage Non-Small-Cell Lung Cancer.

Yang Y, Li G, Li S, Wang Y, Zhao Y, Dong B, Wang J, Zhu R, Chen M. Yang Y, et al. Front Oncol. 2021 Oct 11;11:746785. doi: 10.3389/fonc.2021.746785. eCollection 2021. Front Oncol. 2021. PMID: 34707992 Free PMC article.

6

A mast cell-related prognostic model for non-small cell lung cancer.

Yang Y, Qian W, Zhou J, Fan X. Yang Y, et al. J Thorac Dis. 2023 Apr 28;15(4):1948-1957. doi: 10.21037/jtd-23-362. Epub 2023 Apr 26. J Thorac Dis. 2023. PMID: 37197495 Free PMC article.

7

Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice.

Huang X, Pang G, Mao Z, Li B, Teng Z, Yang Y, Qiu Z, Chen X, Wang P. Huang X, et al. Among authors: yang y. Clin Respir J. 2024 May;18(5):e13761. doi: 10.1111/crj.13761. Clin Respir J. 2024. PMID: 38693705 Free PMC article.

8

Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy.

Zhang M, Zhu L, Liang S, Mao Z, Li X, Yang L, Yang Y, Wang K, Wang P, Chen W. Zhang M, et al. Among authors: yang l, yang y. Front Oncol. 2024 Jun 25;14:1411436. doi: 10.3389/fonc.2024.1411436. eCollection 2024. Front Oncol. 2024. PMID: 38983930 Free PMC article.

9

Natural Antisense Long Noncoding RNA HHIP-AS1 Suppresses Non-Small-Cell Lung Cancer Progression by Increasing HHIP Stability via Interaction with CELF2.

Yang Y, Cheng Y, Mou Y, Tang X, Mu X. Yang Y, et al. Crit Rev Eukaryot Gene Expr. 2022;33(1):67-77. doi: 10.1615/CritRevEukaryotGeneExpr.2022043174. Crit Rev Eukaryot Gene Expr. 2022. PMID: 36374812

10

Identification of costimulatory molecule signatures for evaluating prognostic risk in non-small cell lung cancer.

Yang Y, Lu S, Gu G. Yang Y, et al. Heliyon. 2024 Aug 30;10(17):e36816. doi: 10.1016/j.heliyon.2024.e36816. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39286099 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110,501 results

Search Page

Filters